Terazosin Hydrochloride

Terazosin Hydrochloride__Alpha adrenergic antagonist, and Hsp90 Activator Lenalidomide

Product Name Terazosin Hydrochloride
Description

Alpha adrenergic antagonist, and Hsp90 Activator

Purity >98%
CAS No. 63074-08-8
Molecular Formula C19H25N5O4·HCl
Molecular Weight 423.89
Storage Temperature -20ºC
Shipping Temperature Shipped Ambient
Product Type Antagonist
Solubility Soluble to 20mg/ml in warm water
Source Synthetic
Appearance White to off-white solid
SMILES C1=C(OC)C(=CC2=C1C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC.Cl-.O
InChI InChI=1S/C19H25N5O4.ClH.H2O/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14;;/h10-11,1
InChIKey MWYNOTLRCUQCKD-UHFFFAOYSA-M
Safety Phrases Classification:
Not a hazardous substance or mixture.

Safety Phrases:
S22 – Do not breathe dust.
S24/25 – Avoid contact with skin and eyes.
S36/37/39 – Wear suitable protective clothing, gloves and eye/face protection. Hazard Statements: H302 – Harmful if swallowed.

Cite This Product Terazosin Hydrochloride (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-516)
Alternative Names 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(tetrahydro-2-furanyl)carbonylpiperazine
Research Areas Cancer, Alpha-2 Adrenergic Receptors, Apoptosis, Neuroscience, Neurotransmitter Receptors
PubChem ID 44383
Scientific Background Terazosin (TZ) which is marketed as an alpha1-adrenergic receptor antagonist, has been shown to alleviate organ damaged and increase survival in rodent models of sepsis and stroke in vivo (1). It inhibits apoptosis in macrophages by activation of Pgk1 and Hsp90 (1).
References 1. Chen X., et al. (2015) Nature Chem Biol. 11:19-25.
2. Hancock A.A., et al. (1995) J Recept Signal Transduct Res. 15: 863.
3. Kyncl J.J. (1986) Am J Med. 80:12.